Literature DB >> 24815905

Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: mechanism and kinetics.

A Ninh Pham1, T David Waite2.   

Abstract

Spontaneous oxidation of dopamine (DA) and the resultant formation of free radical species within dopamine neurons of the substantia nigra (SN) is thought to bestow a considerable oxidative load upon these neurons and may contribute to their vulnerability to degeneration in Parkinson's disease (PD). An understanding of DA oxidation under physiological conditions is thus critical to understanding the relatively selective vulnerability of these dopaminergic neurons in PD and may support the development of novel neuro-protective approaches for this disorder. In this study, the oxidation of dopamine (0.2-10μM) was investigated both in the absence and the presence of copper (0.01-0.4μM), a redox active metal that is present at considerable concentrations in the SN, over a range of background chloride concentrations (0.01-0.7M), different oxygen concentrations and at physiological pH7.4. DA was observed to oxidize extremely slowly in the absence of copper and at moderate rates only in the presence of copper but without chloride. The oxidation of DA however was significantly enhanced in the presence of both copper and chloride with the rate of DA oxidation greatest at intermediate chloride concentrations (0.05-0.2M). The variability of the catalytic effect of Cu(II) on DA oxidation at different chloride concentrations can be explained and successfully modeled by appropriate consideration of the reaction of Cu(II) species with DA and the conversion of Cu(I) to Cu(II) through oxygenation. This model suggests that the speciation of Cu(II) and Cu(I) is critically important to the kinetics of DA oxidation and thus the vulnerability to degradation of dopaminergic neuron in the brain milieu.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chloride; Copper; Dopamine; Kinetics; Oxidation; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 24815905     DOI: 10.1016/j.jinorgbio.2014.03.018

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  15 in total

Review 1.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

2.  Synthesis and crystal structure of catena-poly[[tetra-μ-acetato-copper(II)]-μ-6-eth-oxy-N 2,N 4-bis-[2-(pyridin-2-yl)eth-yl]-1,3,5-triazine-2,4-di-amine].

Authors:  Mayokun J Ayodele; Travis C Green; W A Chathuri V Warsapperuma; Malcolm D E Forbes; Alexis D Ostrowski
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-02-26

3.  Controllable bisubstrate multi-colorimetric assay based on peroxidase-like nanozyme and complementary colorharmonic principle for semi-quantitative detection of H2O2 with the naked eye.

Authors:  Min Su; Hongda Chen; Hua Zhang; Zhenxin Wang
Journal:  Mikrochim Acta       Date:  2022-01-31       Impact factor: 5.833

4.  Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.

Authors:  Thomas M Jeitner; Mike Kalogiannis; Boris F Krasnikov; Irving Gomolin; Morgan R Peltier; Graham R Moran
Journal:  Toxicol Sci       Date:  2016-03-29       Impact factor: 4.849

5.  Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines.

Authors:  Andrew F Fischer; Kathryn Mansfield Matera
Journal:  Neurochem Res       Date:  2015-05-09       Impact factor: 3.996

Review 6.  Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yeonggwang Hwang; Naveen Sharma; Duy-Khanh Dang; Bao-Trong Nguyen; Seung-Yeol Nah; Choon-Gon Jang; Guoying Bing; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2021-07-20       Impact factor: 4.946

7.  Effects of pH and Oxidants on the First Steps of Polydopamine Formation: A Thermodynamic Approach.

Authors:  Mikko Salomäki; Lauri Marttila; Henri Kivelä; Tuomo Ouvinen; Jukka Lukkari
Journal:  J Phys Chem B       Date:  2018-06-06       Impact factor: 2.991

8.  Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease.

Authors:  Yingying Sun; A Ninh Pham; Dominic J Hare; T David Waite
Journal:  Front Neurosci       Date:  2018-11-26       Impact factor: 4.677

9.  Tuning the Balance between Fibrillation and Oligomerization of α-Synuclein in the Presence of Dopamine.

Authors:  Shivnetra Saha; Mohammad Ashhar Iqbal Khan; Deepak Mudhara; Shashank Deep
Journal:  ACS Omega       Date:  2018-10-26

10.  Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.

Authors:  Yingying Sun; A Ninh Pham; T David Waite
Journal:  J Neurochem       Date:  2016-05-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.